The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...
The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback